Showing results (911-920 of 942) with videos related to

Sort By:
Pageof 95
Gut|November 29, 2019
British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelinesMatthew D Rutter, James East, Colin J Rees, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2Josie A Blackie, Jackie C Bloomer, Murray J B Brown, et al.
Molecular Cancer Therapeutics|March 3, 2026
JNJ-79032421, a Novel Membrane-restricted Mesothelin-targeting T-cell-engaging Bispecific Antibody for the Treatment of Mesothelin-positive CancersKarine Smans, Thomas Nesspor, Sabine De Breucker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 2025
Increasing HIV Testing During Gonorrhea and Chlamydia Evaluations in Urgent Care and Emergency Departments: A Large Health System InitiativeAllan M Seibert, Michelle Matheu, Whitney R Buckel, et al.
Science (New York, N.Y.)|July 4, 2009
Mars water-ice clouds and precipitationJ A Whiteway, L Komguem, C Dickinson, et al.
Veterinary Surgery : VS|June 27, 2012
Complications and owner assessment of canine total hip replacement: a multicenter internet based surveyKate E Forster, Andrew Wills, Andrew M Torrington, et al.
Life Sciences in Space Research|April 26, 2024
The COSPAR planetary protection policy for missions to Icy Worlds: A review of history, current scientific knowledge, and future directionsP T Doran, A Hayes, O Grasset, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|May 4, 2019
2-Hydroxypropyl-β-cyclodextrin is the active component in a triple combination formulation for treatment of Niemann-Pick C1 diseaseJessica Davidson, Elizabeth Molitor, Samantha Moores, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
The discovery of SB-435495. A potent, orally active inhibitor of lipoprotein-associated phospholipase A(2) for evaluation in manJosie A Blackie, Jackie C Bloomer, Murray J B Brown, et al.
Molecular Therapy. Nucleic Acids|January 17, 2013
Pharmacological Characterization of a Novel ENaCα siRNA (GSK2225745) With Potential for the Treatment of Cystic FibrosisKenneth L Clark, Stephen A Hughes, Pallav Bulsara, et al.
Pageof 95